Evolent Health (EVH) Receivables - Other (2015 - 2021)

Evolent Health has reported Receivables - Other for 7 years, with the latest figure at $190000.0 in Q1 2021.

• On a quarterly basis, Receivables - Other fell 89.16% year-over-year to $190000.0 in Q1 2021; TTM through Mar 2021 was $190000.0, a 89.16% decrease from a year earlier, with the FY2020 full-year figure at $329000.0, down 81.21% from the prior year.
• Receivables - Other was $190000.0 for Q1 2021 at Evolent Health, down from $329000.0 in the prior quarter.
• The five-year high for Receivables - Other was $10.1 million in Q3 2019, with the low at $190000.0 in Q1 2021.
• Average Receivables - Other over 5 years is $4.6 million, with a median of $5.7 million recorded in 2018.
• The sharpest annual moves came in 2018 and 2020: Receivables - Other surged 35.44% in 2018, then plunged 93.33% in 2020.
• Over 5 years, Receivables - Other stood at $5.7 million in 2017, then tumbled by 63.38% to $2.1 million in 2018, then fell by 16.7% to $1.8 million in 2019, then tumbled by 81.21% to $329000.0 in 2020, then slumped by 42.25% to $190000.0 in 2021.
• The last three Receivables - Other figures came in at $190000.0 (Q1 2021), $329000.0 (Q4 2020), and $671000.0 (Q3 2020), per Business Quant data.